Biofrontera
BFRI
12 hedge funds and large institutions have $1.18M invested in Biofrontera in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
6.66% less ownership
Funds ownership: 23.35% → 16.69% (-6.7%)
14% less funds holding
Funds holding: 14 → 12 (-2)
40% less capital invested
Capital invested by funds: $1.97M → $1.18M (-$788K)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$29K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.4K |
| 3 |
JP Morgan Chase
New York
|
+$203 |
| 4 |
Morgan Stanley
New York
|
+$165 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$172K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$81.2K |
| 3 |
Goldman Sachs
New York
|
-$49.7K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$27.3K |
| 5 |
VF
Virtu Financial
New York
|
-$26.4K |
BFRI Hedge Fund Activity: Q1 2025 in Review
12 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2025, worth a combined $1.18M — down 40% from $1.97M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BFRI and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $29K. The largest seller was Rosalind Advisors, cutting an estimated $172K.
- 12 institutional investors held Biofrontera (BFRI) as of Q1 2025, down from 14 in Q4 2024.
- Funds reported $1.18M of Biofrontera stock for Q1 2025, down 40% quarter-over-quarter.
- 3 funds opened new Biofrontera positions in Q1 2025 and 5 closed out, a net change of -2 holders.
- The largest Biofrontera buyer in Q1 2025 was Citadel Advisors, an estimated $29K added.
- The largest Biofrontera seller in Q1 2025 was Rosalind Advisors, an estimated $172K sold.
Based on aggregated 13F filings for Q1 2025.